000 04469cam a2200937 c 4500
001 161748833X
003 DE-627
005 20250624174409.0
007 tu
008 050502s2005 xxu||||| 00| ||eng c
010 _a 2004062719
020 _a0841238995
_c(alk. paper)
_90-8412-3899-5
024 3 _a9780841238992
024 8 _a2004062719
_qIdentnummer
035 _a(DE-D210)CP000004700
035 _a(DE-576)117324264
035 _a(DE-627)161748833X
035 _a(DE-599)BSZ117324264
035 _a(OCoLC)636319705
035 _a(OCoLC)57069166
035 _a(DE-605)HT014465074
040 _aDE-627
_bger
_cDE-627
_erakwb
041 _aeng
044 _cXD-US
050 0 _aRS166.M43 2005
050 0 _aRS166
060 0 _a2006 A-687
060 0 _aQV 290
082 0 _a615/.2
082 0 _a615.2
_qOCLC
084 _a15,3
_2ssgn
084 _aVH 5080
_qhdub
_2rvk
_0(DE-625)rvk/147259:
084 _a44.42
_2bkl
084 _a35.40
_2bkl
245 0 0 _aMedicinal inorganic chemistry
_cJonathan L. Sessler, ed. ...
264 1 _aWashington, D.C.
_bAmerican Chemical Society
_c2005
264 1 _aWashington, DC
_bAmerican Chemical Society
_c2005
300 _a453 S.
_bIll., graph. Darst.
336 _aText
_btxt
_2rdacontent
337 _aohne Hilfsmittel zu benutzen
_bn
_2rdamedia
338 _aBand
_bnc
_2rdacarrier
490 1 _aACS symposium series
_v903
500 _a"Sponsored by the ACS Divisions of Inorganic Chemistry, Inc. and Medicinal Chemistry." - Includes bibliographical references and index
583 1 _aArchivierung prüfen
_c20200919
_fDE-640
_z2
_2pdager
583 1 _aArchivierung prüfen
_c20240324
_fDE-4165
_z3
_2pdager
583 1 _aArchivierung/Langzeitarchivierung gewährleistet
_c20250619
_fSSG
_zSSG Pharmazie
_2pdager
_5DE-84
650 0 _aInorganic compounds
_xTherapeutic use
_xCongresses
650 0 _aMinerals in pharmacology
_xCongresses
650 0 _aOrganometallic compounds
_xTherapeutic use
_xCongresses
650 0 _aInorganic compounds
_xTherapeutic use
_vCongresses
650 0 _aMinerals in pharmacology
_vCongresses
650 0 _aOrganometallic compounds
_xTherapeutic use
_vCongresses
650 2 _aInorganic Chemicals
_xpharmacology
_vCongresses
650 2 _aOrganometallic Compounds
_xpharmacology
_vCongresses
650 2 _aInorganic Chemicals
_xtherapeutic use
_vCongresses
650 2 _aMinerals
_xpharmacology
_vCongresses
650 2 _aOrganometallic Compounds
_xtherapeutic use
_vCongresses
655 7 _aKonferenzschrift
_9433375485
655 7 _aKonferenzschrift
_0(DE-588)1071861417
_0(DE-627)826484824
_0(DE-576)433375485
_2gnd-content
689 0 0 _Ds
_0(DE-588)4002147-6
_0(DE-627)106394339
_0(DE-576)208845941
_aAnorganische Verbindungen
_2gnd
689 0 1 _Ds
_0(DE-588)4045687-0
_0(DE-627)104791454
_0(DE-576)209066377
_aPharmakologie
_2gnd
689 0 _5(DE-627)
689 1 0 _Ds
_0(DE-588)4002147-6
_0(DE-627)106394339
_0(DE-576)208845941
_aAnorganische Verbindungen
_2gnd
689 1 1 _Ds
_0(DE-588)4024069-1
_0(DE-627)104708026
_0(DE-576)208952985
_aHeilmittel
_2gnd
689 1 2 _Ds
_0(DE-588)4132158-3
_0(DE-627)105689769
_0(DE-576)209633220
_aPharmazeutische Chemie
_2gnd
689 1 _5(DE-627)
700 1 _81\p
_aSessler, Jonathan L.
_d1956-
_eHrsg.
_0(DE-588)123321573
_0(DE-627)08248340X
_0(DE-576)293654557
_4edt
_9583
810 2 _aAmerican Chemical Society
_tACS symposium series
_v903
_9903
_w(DE-627)129435597
_w(DE-576)004881354
_w(DE-600)193762-5
_x0097-6156
_7am
856 4 2 _uhttp://www.gbv.de/dms/hbz/toc/ht014465074.pdf
_mV:DE-605
_qpdf/application
_v2008-11-15
_yInhaltsverzeichnis
_3Inhaltsverzeichnis
856 4 2 _uhttp://www.loc.gov/catdir/enhancements/fy0639/2004062719-d.html
_yPublisher description
856 4 2 _uhttp://www.loc.gov/catdir/enhancements/fy0639/2004062719-t.html
_yTable of contents
856 4 2 _uhttp://www.loc.gov/catdir/enhancements/fy0725/2004062719-b.html
_yContributor biographical information
883 _81\p
_acgwrk
_d20250301
_qDE-101
_uhttps://d-nb.info/provenance/plan#cgwrk
889 _w(DE-627)473074559
935 _imdedup
936 r v _aVH 5080
_bKongresse, Symposien
_kChemie und Pharmazie
_kAnorganische Chemie
_kAnorganische Chemie allgemein
_kKongresse, Symposien
_0(DE-627)1271915278
_0(DE-625)rvk/147259:
_0(DE-576)201915278
936 b k _a44.42
_jPharmazeutische Chemie
_0(DE-627)18157179X
936 b k _a35.40
_jAnorganische Chemie: Allgemeines
_0(DE-627)10641044X
942 _cBK
951 _aBO
999 _c4433
_d4433